FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mostafa Nokta

Research Profile

Disorders

Living Beings

Physiology

Procedures

Anatomy

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Mostafa Nokta
Improving acquired immunodeficiency syndrome related cancer outcomes through international collaboration.
Mostafa Nokta
Oral manifestations associated with HIV infection.
David M Asmuth; Nan Wang; Ying Lu; Xiao-Dong Li; Lisa M Reece; Nicholas H A Terry; Richard B Pollard; Mostafa Nokta; James Leary; R Allen White
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mostafa Nokta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Mostafa Nokta
Improving acquired immunodeficiency syndrome related cancer outcomes through international collaboration.
Chinese journal of integrative medicine 2011;17(5):326-8.
2008: Mostafa Nokta
Oral manifestations associated with HIV infection.
Current HIV/AIDS reports 2008;5(1):5-12.
2005: David M Asmuth; Nan Wang; Ying Lu; Xiao-Dong Li; Lisa M Reece; Nicholas H A Terry; Richard B Pollard; Mostafa Nokta; James Leary; R Allen White
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):41-51.
2005: R Allen White; David M Asmuth; Ying Lu; Nan Wang; Xiao-Dong Li; Lisa M Reece; Richard B Pollard; Mostafa Nokta; James Leary; Nicholas H A Terry
Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):32-40.
2005: David A Wohl; Michelle A Kendall; Susan Owens; G Holland; Mostafa Nokta; S A Spector; R Schrier; Susan A Fiscus; M Davis; Mark A Jacobson; Judith S Currier; K Squires; Beverly Alston-Smith; J Andersen; W R Freeman; M Higgins; Francesca J Torriani
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
HIV clinical trials 2005;6(3):136-46.
2004: Michael J Borucki; John Spritzler; David M Asmuth; John W Gnann; Martin S Hirsch; Mostafa Nokta; Francesca T Aweeka; Paul I Nadler; Fred R Sattler; Beverly Alston; Thomas T Nevin; Susan Owens; Karen Waterman; Larry Hubbard; Angela Caliendo; Richard B Pollard
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Antiviral research 2004;64(2):103-11.
2004: Beverly E Sha; Michelle Onorato; John A Bartlett; Ronald J Bosch; Evgenia Aga; Mostafa Nokta; Elizabeth M Adams; Xiao-Dong Li; John Eldridge; Richard B Pollard
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12.
AIDS (London, England) 2004;18(8):1203-6.
2004: Donna Mildvan; Ronald J Bosch; Ryung S. Kim; John Spritzler; David W Haas; Daniel R Kuritzkes; Jonathan Kagan; Mostafa Nokta; Victor DeGruttola; Melanie Moreno; Alan Landay
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response.
The Journal of infectious diseases 2004;189(10):1811-20.
2003: Robert W Shafer; Laura M Smeaton; Gregory Robbins; Victor De Gruttola; Snyder Sally; Richard T D'Aquila; Victoria A Johnson; Gene D Morse; Mostafa Nokta; Ana I Martinez; Barbara Gripshover; Pamposh Kaul; Richard Haubrich; Mary Swingle; S Debra McCarty; STEFANO VELLA; Martin S Hirsch; Thomas C Merigan
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2304-15.
2002: Mostafa Nokta; Xiao-Dong Li; Lena Al-Harthi; Joan Nichols; Anna M Pou; David M Asmuth; Alan Landay; Richard B Pollard
Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
AIDS (London, England) 2002;16(16):2119-27.
2002: Mostafa Nokta; Fiona Holland; Victor De Gruttola; Vincent C Emery; Mark A Jacobson; Paul Griffiths; Richard B Pollard; Judith E Feinberg
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
The Journal of infectious diseases 2002;185(12):1717-22.
2001: S Kundu-Raychaudhuri; Anne Sevin; Patrick D Kilgo; Mostafa Nokta; Richard B Pollard; T C Merigan
Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).
AIDS research and human retroviruses 2001;17(15):1371-8.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; Anna M Pou; David M Asmuth; Richard B Pollard
Homeostasis of naive and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of human immunodeficiency virus infection.
The Journal of infectious diseases 2001;183(9):1336-42.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; M Mallen; Anna M Pou; David M Asmuth; Richard B Pollard
Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
AIDS (London, England) 2001;15(2):161-9.
2000: Janet L Lathey; Donald J Brambilla; Maureen M Goodenow; Mostafa Nokta; Suraiya Rasheed; E B Siwak; James Bremer; Diana D Huang; Y Yi; Patricia Reichelderfer; R G Collman
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
Journal of leukocyte biology 2000;68(3):324-30.
2000: Rebecca A Betensky; Elizabeth Connick; JL Devers; Alan L Landay; Mostafa Nokta; Susan F Plaeger; Howard M Rosenblatt; John L Schmitz; F Valentine; Diane Wara; A Weinberg; Howard M Lederman
Shipment impairs lymphocyte proliferative responses to microbial antigens.
Clinical and diagnostic laboratory immunology 2000;7(5):759-63.
2000: John L Fahey; Najib Aziz; John Spritzler; Susan F Plaeger; P Nishanian; Janet L Lathey; J Seigel; Alan L Landay; R Kilarui; John L Schmitz; C White; Diane Wara; R Akridge; J Cutili; Steven D Douglas; J Reuben; William T Shearer; Mostafa Nokta; R Polland; Robert T Schooley; Deshratn Asthana; Y Mizrachi; M Waxdal
Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.
Clinical and diagnostic laboratory immunology 2000;7(4):540-8.
2000: Mostafa Nokta; P Turk; Kim Loesch; Richard B Pollard
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.
Clinical and diagnostic laboratory immunology 2000;7(3):412-6.
2000: Beverly E Sha; Victoria A Johnson; Michelle A Kendall; Richard Haubrich; Mostafa Nokta; K Lamb; Robert Zackin; C D Nail; Judith S Currier
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels.
AIDS (London, England) 2000;14(6):746-8.
2000: Marie L Landry; S Stanat; Karen K Biron; D Brambilla; W Britt; J Jokela; Sunwen Chou; W Lawrence Drew; Alejo Erice; Bruce L Gilliam; Nell S Lurain; J Manischewitz; Richard C Miner; Mostafa Nokta; Patricia Reichelderfer; S Spector; A Weinberg; Belinda Yen-Lieberman; Clyde S Crumpacker
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.
Antimicrobial agents and chemotherapy 2000;44(3):688-92.
1999: Mostafa Nokta; R Rossero; Joan Nichols; M Rosenbaum; Richard B Pollard
Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
AIDS research and human retroviruses 1999;15(3):255-64.
1998: J M McSharry; Nell S Lurain; George L Drusano; A Landay; J Manischewitz; Mostafa Nokta; Maurice O'Gorman; HM Shapiro; A Weinberg; Patricia Reichelderfer; Clyde S Crumpacker
Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.
Journal of clinical microbiology 1998;36(4):958-64.
1998: Todd C Pappas; S Alagarsamy; Richard B Pollard; Mostafa Nokta
HIV decreases glutamate transport in SK-N-MC neuroblastoma cells.
Journal of neurovirology 1998;4(1):69-79.
1997: Mostafa Nokta; R Rossero; Kim Loesch; Richard B Pollard
Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
AIDS research and human retroviruses 1997;13(18):1633-8.
1997: Mostafa Nokta; S G Hausrath; Richard B Pollard
Emerging treatments for viral retinitis.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;7(6):423-32.
1996: Mostafa Nokta; M I Hassan; K Loesch; Richard B Pollard
Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.
The Journal of clinical investigation 1996;97(11):2635-41.
1995: Mostafa Nokta; M I Hassan; K A Loesch; Richard B Pollard
HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes.
Virology 1995;208(2):590-600.
1994: Mostafa Nokta; M I Hassan; J A Morgan; K A Loesch; Richard B Pollard
Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1994;207(3):284-91.
1994: Mostafa Nokta; M D Tolpin; P I Nadler; Richard B Pollard
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication.
Antiviral research 1994;24(1):17-26.
1994: M I Hassan; Mostafa Nokta; Richard B Pollard
Cytomegalovirus DNA polymerase activity and an 80 kDa-associated polypeptide: a potential diagnostic tool for CMV disease.
Journal of virological methods 1994;46(2):207-22.
1993: M I Hassan; Mostafa Nokta; Richard B Pollard
Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1993;204(2):216-23.
1993: Mostafa Nokta; Thomas Albrecht; Richard B Pollard
Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function.
Immunopharmacology 1993;26(2):181-5.
1992: Mostafa Nokta; Richard B Pollard
Human immunodeficiency virus replication: modulation by cellular levels of cAMP.
AIDS research and human retroviruses 1992;8(7):1255-61.
1992: Mostafa Nokta; J Belli; Richard B Pollard
X-irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(3):402-8.
1991: H M Shafik; Mostafa Nokta; Richard B Pollard
Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients.
Antiviral research 1991;16(2):205-12.
1991: Mostafa Nokta; J P Loh; S M Douidar; A E Ahmed; Richard B Pollard
Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients.
Journal of interferon research 1991;11(3):159-64.
1991: Mostafa Nokta; D Matzke; M Jennings; E Schlick; P I Nadler; Richard B Pollard
In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991;197(2):144-9.
1991: A E Ahmed; S Jacob; J P Loh; Satwant K Samra; Mostafa Nokta; Richard B Pollard
Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice.
The Journal of pharmacology and experimental therapeutics 1991;257(1):479-86.
1991: Mostafa Nokta; Richard B Pollard
Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells.
Virology 1991;181(1):211-7.
1991: Michael Fons; Mostafa Nokta; S Cerruti-Sola; Thomas Albrecht
Amiloride inhibition of human cytomegalovirus replication.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991;196(1):89-96.
1990: Mostafa Nokta; Richard B Pollard
Patterns of interferon-gamma production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection.
Journal of interferon research 1990;10(2):173-81.
1989: Mostafa Nokta; Richard B Pollard
Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection.
Antiviral research 1989;11(4):191-202.
1988: Mostafa Nokta; Michael Fons; Douglas C. Eaton; Thomas Albrecht
Cytomegalovirus: sodium entry and development of cytomegaly in human fibroblasts.
Virology 1988;164(2):411-9.
1987: Mostafa Nokta; Douglas C. Eaton; O S Steinsland; Thomas Albrecht
Ca2+ responses in cytomegalovirus-infected fibroblasts of human origin.
Virology 1987;157(2):259-67.
1984: Thomas Albrecht; J L Li; D Speelman; R Ball; Mostafa Nokta; Michael Fons; C H Lee; O Steinsland; W C Thompson; D H Carney
Cellular responses to human cytomegalovirus infection.
Birth defects original article series 1984;20(1):21-34.